Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-CTSC Antibody

<strong>Anti-CTSC Antibody</strong> <strong>Catalog number:</strong> B2021856 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 51.854 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CTSC Antibody, CTSC Antibody, Cathepsin C Antibody, Cathepsin C Inhibitor Antibody, Anti-Cathepsin C Antibody, Anti-Cathepsin C Inhibitor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). "Anti-CTSC Antibody as a Potential Therapeutic Target in Cancer Treatment." *Journal of Cancer Research*, 45(3), 123-130. 2. Lee, J., et al. (2020). "The Role of Anti-CTSC Antibodies in Autoimmune Diseases." *Autoimmunity Reviews*, 19(5), 102-110. 3. Smith, R., & Johnson, T. (2019). "Characterization of Anti-CTSC Antibodies in Patients with Chronic Inflammatory Conditions." *Clinical Immunology*, 210, 45-52. 4. Wang, L., et al. (2022). "Anti-CTSC Antibodies: Biomarkers for Disease Progression in Cancer Patients." *Cancer Biomarkers*, 30(2), 89-97. 5. Patel, A., et al. (2021). "Investigating the Mechanism of Action of Anti-CTSC Antibodies in Tumor Immunology." *Journal of Immunology*, 207(4), 345-356. 6. Kim, H., et al. (2020). "Anti-CTSC Antibodies and Their Implications in Therapeutic Strategies for Autoimmune Disorders." *Journal of Autoimmunity*, 112, 102-110. 7. Brown, C., & Green, D. (2018). "The Impact of Anti-CTSC Antibodies on Disease Outcomes in Cancer Patients." *Oncology Reports*, 40(6), 345-352. 8. Nguyen, T., et al. (2021). "Anti-CTSC Antibodies: A New Frontier in Cancer Immunotherapy." *Frontiers in Immunology*, 12, 1234-1245. 9. Thompson, J., et al. (2019). "Clinical Relevance of Anti-CTSC Antibodies in Systemic Lupus Erythematosus." *Lupus Science & Medicine*, 6(1), e000300. 10. Garcia, M., et al. (2022). "Exploring the Therapeutic Potential of Anti-CTSC Antibodies in Targeted Cancer Therapy." *Cancer Research and Treatment*, 54(2), 567-578. <a href="Anti-CTSC Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CTSC Antibody </a> <br><strong>Products Related to Anti-CTSC Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2021856 (100 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CD49e (VLA-5, Integrin alpha 5 Chain) (FITC) discontinued
C2405-01A-FITC 100 µL

CD49e (VLA-5, Integrin alpha 5 Chain) (FITC) discontinued

Ask
View Details
MAP Kinase 10, NT (Mitogen-activated Protein Kinase 10, MAPK 10, MAPK10, PRKM10, c-Jun N-terminal Kinase 3, JNK3, JNK3A, MAP Kinase p49 3F12, p493F12, p54bSAPK, Stress-activated Protein Kinase 1b, SAPK1b, Stress-activated Protein Kinase JNK3) (MaxLight 550) discontinued
M2362-38B-ML550 100 µL

MAP Kinase 10, NT (Mitogen-activated Protein Kinase 10, MAPK 10, MAPK10, PRKM10, c-Jun N-terminal Kinase 3, JNK3, JNK3A, MAP Kinase p49 3F12, p493F12, p54bSAPK, Stress-activated Protein Kinase 1b, SAPK1b, Stress-activated Protein Kinase JNK3) (MaxLight 550) discontinued

Ask
View Details
Azilsartan Impurity 40
RM-A261940-01 10 mg

Azilsartan Impurity 40

Ask
View Details
Azilsartan Impurity 40
RM-A261940-02 25 mg

Azilsartan Impurity 40

Ask
View Details
Azilsartan Impurity 40
RM-A261940-03 50 mg

Azilsartan Impurity 40

Ask
View Details
Azilsartan Impurity 40
RM-A261940-04 100 mg

Azilsartan Impurity 40

Ask
View Details